Impact of Platelet-to-HDL-Cholesterol Ratio on Long-Term Mortality in Coronary Artery Disease Patients with or Without Type 2 Diabetes: Insights from a Chinese Multicenter Cohort

References

• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra043430
   PubMed Web of Science ®Google Scholar
• Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J AM Coll Cardiol. 2004;43(2):169–175. doi:10.1016/j.jacc.2003.08.036
   PubMed Web of Science ®Google Scholar
• Sharif S, Van der Graaf Y, Cramer MJ, et al. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):220. doi:10.1186/s12933-021-01409-0
   PubMed Web of Science ®Google Scholar
• Batra G, Ghukasyan Lakic T, Lindbäck J, et al. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiol. 2021;6(12):1440–1445. doi:10.1001/jamacardio.2021.3079
   PubMed Web of Science ®Google Scholar
• Antonopoulos AS, Angelopoulos A, Papanikolaou P, et al. Biomarkers of vascular inflammation for cardiovascular risk prognostication: a meta-analysis. JACC Cardiovasc Imaging. 2022;15(3):460–471. doi:10.1016/j.jcmg.2021.09.014
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Y, Chen X, et al. The systemic inflammation index predicts poor clinical prognosis in patients with initially diagnosed acute coronary syndrome undergoing primary coronary angiography. J Inflamm Res. 2023;16:5205–5219. doi:10.2147/JIR.S435398
   PubMed Web of Science ®Google Scholar
• Pretorius L, Thomson GJA, Adams RCM, Nell TA, Laubscher WA, Pretorius E. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):141. doi:10.1186/s12933-018-0783-z
   PubMedGoogle Scholar
• Hwang JY, Kwon YJ, Choi WJ, Jung DH. Platelet count and 8-year incidence of diabetes: the Korean Genome and Epidemiology Study. Diabet Res Clin Pract. 2018;143:301–309. doi:10.1016/j.diabres.2018.07.033
   PubMed Web of Science ®Google Scholar
• Francuz P, Kowalczyk J, Swoboda R, et al. Platelet count and volume indices in patients with contrast-induced acute kidney injury and acute myocardial infarction treated invasively. Kardiol Pol. 2015;73(7):520–526. doi:10.5603/KP.a2015.0054
   PubMed Web of Science ®Google Scholar
• van der Stoep M, Korporaal SJ, Van Eck M. High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res. 2014;103(3):362–371. doi:10.1093/cvr/cvu137
   PubMed Web of Science ®Google Scholar
• Nofer JR, Brodde MF, Kehrel BE. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37(7):726–735. doi:10.1111/j.1440-1681.2010.05377.x
   PubMed Web of Science ®Google Scholar
• Constantinou C, Karavia EA, Xepapadaki E, et al. Advances in high-density lipoprotein physiology: surprises, overturns, and promises. Am J Physiol Endocrinol Metab. 2016;310(1):E1–E14. doi:10.1152/ajpendo.00429.2015
   PubMed Web of Science ®Google Scholar
• Jia C, Anderson JLC, Gruppen EG, et al. High-density lipoprotein anti-inflammatory capacity and incident cardiovascular events. Circulation. 2021;143(20):1935–1945. doi:10.1161/CIRCULATIONAHA.120.050808
   PubMed Web of Science ®Google Scholar
• Pirillo A, Catapano AL, Norata GD. Biological consequences of dysfunctional HDL. Curr Med Chem. 2019;26(9):1644–1664. doi:10.2174/0929867325666180530110543
   PubMed Web of Science ®Google Scholar
• de Lima-Junior JC, Virginio VWM, Moura FA, et al. Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity. Nutr, Metab Cardiovasc Dis. 2020;30(2):254–264. doi:10.1016/j.numecd.2019.09.017
   PubMed Web of Science ®Google Scholar
• Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study. J Am Heart Assoc. 2021;10(7):e016947. doi:10.1161/JAHA.120.016947
   PubMed Web of Science ®Google Scholar
• Lu CF, Cang XM, Liu WS, et al. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020. Lipids Health Dis. 2023;22(1):130. doi:10.1186/s12944-023-01861-9
   PubMed Web of Science ®Google Scholar
• Jialal I, Jialal G, Adams-Huet B. The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes Metab Res Rev. 2021;37(6):e3403. doi:10.1002/dmrr.3403
   PubMed Web of Science ®Google Scholar
• Kelley EE, Paes AM, Yadav H, Quijano C, Cassina A, Trostchansky A. Interplay between Oxidative Stress and Metabolism in Signalling and Disease 2016. Oxid Med Cell Longev. 2017;2017:7013972. doi:10.1155/2017/7013972
   PubMed Web of Science ®Google Scholar
• Plutzky J. Inflammation in atherosclerosis and diabetes mellitus. Rev Endocr Metab Disord. 2004;5(3):255–259. doi:10.1023/B:REMD.0000032414.17672.5c
   PubMed Web of Science ®Google Scholar
• Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246–1258. doi:10.4239/wjd.v6.i13.1246
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58. doi:10.2174/138161211795049804
   PubMed Web of Science ®Google Scholar
• Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–351. doi:10.1161/CIRCRESAHA.117.310795
   PubMed Web of Science ®Google Scholar
• Vinholt PJ, Hvas AM, Frederiksen H, Bathum L, Jørgensen MK, Nybo M. Platelet count is associated with cardiovascular disease, cancer and mortality: a population-based cohort study. Thromb Res. 2016;148:136–142. doi:10.1016/j.thromres.2016.08.012
   PubMed Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357(24):2482–2494. doi:10.1056/NEJMra071014
   PubMed Web of Science ®Google Scholar
• Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666–682. doi:10.1038/s41569-021-00552-1
   PubMed Web of Science ®Google Scholar
• Ly HQ, Kirtane AJ, Murphy SA, et al. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). AM J Cardiol. 2006;98(1):1–5. doi:10.1016/j.amjcard.2006.01.046
   PubMed Web of Science ®Google Scholar
• Jesri A, Okonofua EC, Egan BM. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens. 2005;7(12):705–711; quiz 712–703. doi:10.1111/j.1524-6175.2005.04809.x
   Google Scholar
• Camont L, Lhomme M, Rached F, et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol. 2013;33(12):2715–2723. doi:10.1161/ATVBAHA.113.301468
   PubMed Web of Science ®Google Scholar
• Rohatgi A, Westerterp M, von Eckardstein A, Remaley A, Rye KA. HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation. 2021;143(23):2293–2309. doi:10.1161/CIRCULATIONAHA.120.044221
   PubMed Web of Science ®Google Scholar
• Tuteja S, Rader DJ. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm. Clin Pharmacol Ther. 2014;96(1):48–56. doi:10.1038/clpt.2014.79
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Manoochehri H, Gheitasi R, Pourjafar M, Amini R, Yazdi A. Investigating the relationship between the severity of coronary artery disease and inflammatory factors of MHR, PHR, NHR, and IL-25. Med J Islam Repub Iran. 2021;35:85. doi:10.47176/mjiri.35.85
   PubMedGoogle Scholar
• Szymańska P, Luzak B, Siarkiewicz P, Golański J. Platelets as potential non-traditional cardiovascular risk factor-analysis performed in healthy donors. Int J Mol Sci. 2023;24(19):14914. doi:10.3390/ijms241914914
   PubMed Web of Science ®Google Scholar
• Winzap P, Davies A, Klingenberg R, et al. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61. Cardiovasc Diabetol. 2019;18(1):142. doi:10.1186/s12933-019-0946-6
   PubMed Web of Science ®Google Scholar
• Pennells L, Kaptoge S, Østergaard HB. SCORE2-diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023;44(28):2544–2556. doi:10.1093/eurheartj/ehad260
   PubMed Web of Science ®Google Scholar
• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–234. doi:10.1056/NEJM199807233390404
   PubMed Web of Science ®Google Scholar
• Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013;30(7):803–817. doi:10.1111/dme.12159
   PubMed Web of Science ®Google Scholar
• Yosten GL, Maric-Bilkan C, Luppi P, Wahren J. Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab. 2014;307(11):E955–E968. doi:10.1152/ajpendo.00130.2014
   PubMed Web of Science ®Google Scholar
• Toprak K, Kaplangoray M, Palice A, Ercan E. The impact of C-peptide and diabetes mellitus on coronary ectasia and effect of coronary ectasia and C-peptide on long-term outcomes: a retrospective cohort study. Int J Clin Pract. 2022;2022:7910566. doi:10.1155/2022/7910566
   PubMed Web of Science ®Google Scholar
• Toprak K, Kaplangöray M, Memioğlu T, et al. HbA1c/C-peptide ratio is associated with angiographic thrombus burden and short-term mortality in patients presenting with ST-elevation myocardial infarction. Blood Coagul Fibrinolysis. 2023;34(6):385–395.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22. doi:10.1056/NEJMoa1812792
   PubMed Web of Science ®Google Scholar
• Clifton P, Sullivan D, Baker J, et al. Abstract 12594: pharmacodynamic effect of ARO-APOC3, an investigational hepatocyte-targeted RNA interference therapeutic targeting apolipoprotein C3, in patients with hypertriglyceridemia and multifactorial chylomicronemia. Circulation. 2020;142(Suppl_3):A12594. doi:10.1161/circ.142.suppl_3.12594
   Google Scholar
• Borén J, Packard CJ, Taskinen MR. The roles of ApoC-III on the metabolism of triglyceride-rich lipoproteins in humans. Front Endocrinol. 2020;11:474. doi:10.3389/fendo.2020.00474
   PubMed Web of Science ®Google Scholar
• Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005;25(7):1512–1518. doi:10.1161/01.ATV.0000170133.43608.37
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8(11):1227–1234. doi:10.1038/nm1102-1227
   PubMed Web of Science ®Google Scholar
• Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 2019;122:154157. doi:10.1016/j.cyto.2017.09.013
   PubMed Web of Science ®Google Scholar
• Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161(1):1–16. doi:10.1016/S0021-9150(01)00651-7
   PubMed Web of Science ®Google Scholar
• Nagao M, Nakajima H, Toh R, Hirata KI, Ishida T. Cardioprotective effects of high-density lipoprotein beyond its anti-atherogenic action. J Atheroscler Thromb. 2018;25(10):985–993. doi:10.5551/jat.RV17025
   PubMed Web of Science ®Google Scholar
• Odegaard AO, Jacobs DR, Sanchez OA, Goff DC, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15(1):51. doi:10.1186/s12933-016-0369-6
   PubMedGoogle Scholar
• Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961–967. doi:10.1007/s00125-015-3520-0
   PubMed Web of Science ®Google Scholar
• Peng L, Yang J, Lu X, et al. Effects of biological variations on platelet count in healthy subjects in China. Thromb Haemost. 2004;91(2):367–372. doi:10.1160/TH03-05-0276
   PubMed Web of Science ®Google Scholar